DePuy Orthopaedics Newswire

Comprehensive Real-Time News Feed for DePuy Orthopaedics.

Results 1 - 20 of 388 in DePuy Orthopaedics

  1. Johnson & Johnson's shared services search comes amid a cost-cutting moveRead the original story w/Photo

    Friday | Business Journal

    The search for a North American headquarters for a shared services operation by Johnson & Johnson Services comes amid a $1 billion cost-cutting initiative by its parent company, Johnson & Johnson Inc. .

    Comment?

  2. DePuy Orthopaedics Tells Courts it Will Settle Additional ASR Hip CasesRead the original story w/Photo

    Friday | PRWeb

    On February 20, 2014, the Settlement Oversight Committee and DePuy Orthopaedics announced that an agreement was reached to effectively extend the existing U.S. Settlement Program to U.S. citizens with an ASR hip which was revised on or before January 31, 2015. According to the original terms of the U.S. Settlement Program, eligible claimants must have had a revision surgery prior to August 31, 2013.

    Comment?

  3. Johnson & Johnson: The Benefit Of A Stagnant Share PriceRead the original story w/Photo

    Thursday Feb 26 | Seeking Alpha

    Yet if you're a net buyer, there is a huge benefit in seeing a stagnant share price coupled with a solid business. On December 31st of 2007, shares of Johnson & Johnson closed at a price around $67.

    Comment?

  4. House panel endorses banning contact lens pricing floorsRead the original story w/Photo

    Thursday Feb 26 | Local NEWS 8

    An Internet firm that sells contact lenses has cleared its first hurdle in persuading the Idaho Legislature to ban manufacturers from cutting off retailers that don't sell their product at a set minimum price. The Idaho House and Welfare Committee unanimously voted Thursday to send the bill to the House floor for a full vote.

    Comment?

  5. Johnson & Johnson Announces Formation Of New Health And Wellness...Read the original story

    Wednesday Feb 25 | BioSpace

    Johnson & Johnson Announces Formation Of New Health And Wellness Platform Designed To Transform Health Care Delivery And Improve The Patient Experience /PRNewswire/ -- Johnson & Johnson today announced the formation of a new health and wellness platform that leverages the breadth of capabilities across its businesses. Johnson & Johnson Health and Wellness Solutions, Inc. will facilitate the development and implementation of programs that focus on wellness and prevention, behavioral health, and chronic disease support, all focusing on improving the quality and vitality of life.

    Comment?

  6. Thursday newspaper round-up: HSBC, RBS, PharmacyclicsRead the original story

    Wednesday Feb 25 | Live Charts

    HSBC boss Stuart Gulliver apologised to MPs on Wednesday for the "unacceptable events" at the bank's Swiss subsidiary following revelations about tax-avoidance activities in the mid-2000s, reports The Independent. He said it had caused "damage to trust and confidence" in the company.

    Comment?

  7. VMWare pinches Juniper Networks CIORead the original story

    Wednesday Feb 25 | Aurora Era-Banner

    VMware has stolen the chief information officer of Juniper Networks after its own CIO Tony Scott took a job with US president Barack Obama . Bask Iyer will head up the virtualisation company's global information and technology department, having previously worked on IT for healthcare firms Johnson & Johnson and GlaxoSmithKline, as well as manufacturers Honeywell.

    Comment?

  8. Xarelto Lawsuit News: Bayer and Johnson & Johnson Pursue Additional...Read the original story

    Wednesday Feb 25 | Sys-Con Media

    According to Drug Watch, the announcement was made last month by Bayer and J&J, and they seek further federal approvals for Xarelto for stroke patients. The public announcement was made amidst the news that plaintiffs have continued to file lawsuits over the companies, and in December and January, judges both in consolidated cases into multidistrict litigation as well as a mass tort program.

    Comment?

  9. J&J settles more defective hip device lawsuitsRead the original story w/Photo

    Monday Feb 23 | West Australian

    Johnson & Johnson has reached an agreement to settle some 1,400 claims over defective hip replacement devices, a spokeswoman for the health care giant said Monday. The agreement extends the benefits of a 2013 settlement with plaintiffs involving about 8,000 cases over ASR Hip System devices that cost the company $2.5 billion.

    Comment?

  10. Interesting October Stock Options for Johnson & JohnsonRead the original story w/Photo

    Monday Feb 23 | Forbes.com

    Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the October expiration for JNJ.

    Comment?

  11. Medical firm seeks overseas spurRead the original story w/Photo

    Sunday Feb 22 | The Standard

    Beijing Chunlizhengda Medical Instruments has shifted to Hong Kong from Shenzhen for its planned initial public offering, aimed at raising funds to finance overseas expansion. It has filed an IPO application with local regulators.

    Comment?

  12. Why Microsoft's Massive Debt Sale Is a Savvy MoveRead the original story

    Sunday Feb 22 | The Motley Fool

    When it comes to investing, debt is often a scary word. Investors are right to be wary of companies that keep a lot of debt on the balance sheet.

    Comment?

  13. The $10 Billion Reason That This Tiny Biotech Stock Could SoarRead the original story w/Photo

    Sunday Feb 22 | The Motley Fool

    If Portola can demonstrate that betrixaban can control bleeding in hospital and post-discharge patients, it could become a big player in the $10 billion market for anticoagulants. Displacing a long-standing leader Warfarin has been used for decades by doctors to help keep blood flowing freely in heart disease and post-operative patients.

    Comment?

  14. Federal Court's Selection of DePuy Pinnacle Hip Lawsuits as...Read the original story w/Photo

    Friday Feb 20 | PRWeb

    ... stayed pending further order of the Court, and following the completion of bellwether trials. (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation, MDL No. 2244) "Bellwether trials are an important milestone in any ...

    Comment?

  15. Agencies line up for Benecol UK businessRead the original story

    Thursday Feb 19 | Brand Republic

    Benecol, the cholesterol-lowering food brand, is in talks with UK agencies as it prepares for a new global growth plan. The company, which is owned by the Finnish food group Raisio, was previously managed by the Johnson & Johnson subsidiary Cilag in the UK.

    Comment?

  16. How to Manage Healthcare Construction Environmental RisksRead the original story w/Photo

    Wednesday Feb 18 | Environmental Leader

    Environmental risks facing new construction or renovation of healthcare facilities can jeopardize patient health and lead to significant financial losses, according to an advisory published by ACE Group . Regulatory changes, increasing competitive pressures and rapid technological advances are transforming the construction of medical facilities, the advisory says.

    Comment?

  17. Boston Scientific settles $7.2B lawsuit brought by Johnson & Johnson for $600MRead the original story w/Photo

    Wednesday Feb 18 | Business Journal

    Boston Scientific Corp. has settled a lawsuit in which competitor Johnson & Johnson sought $7.2 billion in damages for $600 million. Shares of the Marlborough-based medical device giant were up 8 percent in after hour trading on the news, which brings closure to litigation which has been hanging over its head since its 2006 acquisition of Guidant.

    Comment?

  18. Boston Scientific to pay Johnson & Johnson $600M to settle suitRead the original story w/Photo

    Tuesday Feb 17 | Star Tribune

    One of the longest-running lawsuits related to a merger was settled on Tuesday when Boston Scientific agreed to pay Johnson & Johnson $600 million in connection with an 11-year-old deal gone awry. While that is a substantial payment, it is far less than the more than $7 billion in damages that Johnson & Johnson sought in relation to its botched acquisition of Guidant, a medical device company, in 2004.

    Comment?

  19. Boston Scientific will pay Johnson & Johnson $600MRead the original story w/Photo

    Tuesday Feb 17 | NewsOK.com

    Boston Scientific will pay $600 million to settle with drugmaker Johnson & Johnson over the medical device maker's $27 billion acquisition of Guidant Corp. in 2006. Boston Scientific said Tuesday that Johnson & Johnson had wanted $7 billion in damages but will dismiss its lawsuit.

    Comment?

  20. VIG, ENOR: Big ETF OutflowsRead the original story w/Photo

    Tuesday Feb 17 | Forbes.com

    Our mission at Market News Video is to produce and distribute quality online videos about the stock markets and publicly traded companies. We achieve our mission by delivering videos to visitors to our MarketNewsVideo.com website and through our distribution partners.

    Comment?